Bradley, Amber M.
~ 4500  Ergebnisse:
Personensuche X
?
 
?
 
?
4

Intravenous Busulfan Pharmacokinetics in Conditioning Regim..:

Bradley, Amber M. ; Evans, Sarah ; DeRemer, David.
Biology of Blood and Marrow Transplantation.  19 (2013)  2 - p. S373-S374 , 2013
 
?
5

Successful Use of Intrathecal Carboxypeptidase G2 for Intra..:

Bradley, Amber M. ; Buie, Larry W. ; Kuykendal, Adam.
Clinical Lymphoma Myeloma and Leukemia.  13 (2013)  2 - p. 166-170 , 2013
 
?
6

Brentuximab vedotin: An anti-CD30 antibody–drug conjugate:

Bradley, Amber M. ; Devine, Meghan ; DeRemer, David
American Journal of Health-System Pharmacy.  70 (2013)  7 - p. 589-597 , 2013
 
?
8

Survey of learning opportunities in academia for pharmacy r..:

Manasco, Kalen B. ; Bradley, Amber M. ; Gomez, Tad A.
American Journal of Health-System Pharmacy.  69 (2012)  16 - p. 1410-1414 , 2012
 
?
9

Neutropenia‐Associated Outcomes in Adults with Acute Myeloi..:

Bradley, Amber M. ; Deal, Allison M. ; Buie, Larry W..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  32 (2012)  12 - p. 1070-1077 , 2012
 
?
10

Implementation of an individualized argatroban protocol in ..:

Bradley, Amber M. ; Branan, Trisha
American Journal of Health-System Pharmacy.  68 (2011)  14 - p. 1292-1293 , 2011
 
?
12

Comorbidities and Prescribed Medications in Patients With o..:

Dana, Reza ; Bradley, John L. ; Guerin, Annie...
American Journal of Ophthalmology.  198 (2019)  - p. 181-192 , 2019
 
?
13

Estimated Prevalence and Incidence of Dry Eye Disease Based..:

Dana, Reza ; Bradley, John L. ; Guerin, Annie...
American Journal of Ophthalmology.  202 (2019)  - p. 47-54 , 2019
 
1-15